The effectiveness of buprenorphine for treating cancer pain: an abridged Cochrane review

M Schmidt-Hansen, M Taubert… - BMJ supportive & …, 2016 - spcare.bmj.com
Objectives To assess the effectiveness and tolerability of buprenorphine for cancer pain in
adults and children. Methods We searched CENTRAL, MEDLINE, EMBASE, ISI Web of …

A meta-analysis of efficacy and tolerability of buprenorphine for the relief of cancer pain

C Naing, PN Yeoh, K Aung - Springerplus, 2014 - Springer
This study aimed to synthesize available evidence on the analgesic efficacy of
buprenorphine in treating cancer pain and related adverse effects. We searched electronic …

A narrative review of buprenorphine in adult cancer pain

M Degnan, SA Mousa - Expert Review of Clinical Pharmacology, 2020 - Taylor & Francis
Introduction Adult cancer pain is a disease state battled on a global scale. Proper pain
management is essential to prevent health complications and promote patient well-being …

Buprenorphine for treating cancer pain

M Schmidt‐Hansen, N Bromham… - Cochrane Database …, 2015 - cochranelibrary.com
Background Many patients with cancer experience moderate to severe pain that requires
treatment with strong analgesics. Buprenorphine, fentanyl and morphine are examples of …

Safety and efficacy of transdermal buprenorphine for the relief of cancer pain

C Naing, K Aung, V Racloz, PN Yeoh - Journal of cancer research and …, 2013 - Springer
Purpose This study aimed to synthesize the available evidence on the efficacy and safety of
transdermal (TD) buprenorphine. Methods We searched studies in electronic databases …

Managing severe cancer pain: the role of transdermal buprenorphine: a systematic review

S Deandrea, O Corli, I Moschetti… - Therapeutics and clinical …, 2009 - Taylor & Francis
Pain is a frequent and important symptom in cancer patients. Among the available strong
opioids, transdermal buprenorphine has been licensed in Europe since 2002, and results …

Should Buprenorphine Be Considered a First-Line Opioid for the Treatment of Moderate to Severe Cancer Pain?

M Chwistek, D Sherry, L Kinczewski, MJ Silveira… - Journal of Pain and …, 2023 - Elsevier
Cancer pain remains a significant problem worldwide, affecting more than half of patients
receiving anti-cancer treatment and most patients with advanced disease. Opioids remain …

[引用][C] Buprenorphine for treating cancer pain

CM Naing, K Aung, PN Yeoh - Cochrane Database of …, 2013 - cochranelibrary.com
Background Many patients with cancer experience moderate to severe pain that requires
treatment with strong analgesics. Buprenorphine, fentanyl and morphine are examples of …

The role of transdermal buprenorphine in the treatment of cancer pain: an expert panel consensus

JV Pergolizzi Jr, S Mercadante… - … medical research and …, 2009 - Taylor & Francis
Background: The semi-synthetic opioid, buprenorphine, has the general structure of
morphine but differs from it in significant ways, both pharmacologically and clinically. A …

[HTML][HTML] Efficacy and safety of transdermal buprenorphine: a randomized, placebo-controlled trial in 289 patients with severe cancer pain

P Poulain, W Denier, J Douma, K Hoerauf… - Journal of pain and …, 2008 - Elsevier
Strong opioids are recommended for treating severe cancer pain in the advanced stages of
the disease. Few data are available concerning the efficacy of buprenorphine in cancer …